Avanos Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Avanos Medical generated cash of $32,400,000, which is less than the previous year. Cash used in financing activities reached the amount of -$94,200,000 last year. Net change in cash is therefore -$40,000,000.
Cash Flow
| 2014 | 147.9M | -70.7M | 29.2M |
|---|---|---|---|
| 2015 | 97.6M | -62.6M | -50.6M |
| 2016 | 188.8M | -200.9M | -1.4M |
| 2017 | 144.2M | -43.1M | 2.2M |
| 2018 | -145.6M | 639.5M | -324.4M |
| 2019 | -74.5M | -108.1M | 1.5M |
| 2020 | -2.5M | -24.2M | -70M |
| 2021 | 87.3M | -21M | -55.3M |
| 2022 | 90.9M | -135.4M | 56.7M |
| 2023 | 32.4M | 21.6M | -94.2M |
AVNS Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 127.7M | 118.5M | 111.5M | 205.3M | 384.5M | 219.7M | 113.7M | 129.5M | 149M | 44.1M |
Operating activities | ||||||||||
Net income | -61.8M | 50.5M | 5.2M | -27.2M | -45.9M | 57.5M | 79.3M | 39.8M | -426.3M | 27.1M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 46.1M | 47.7M | 38.3M | 42.9M | 36.9M | 33.5M | 59.5M | 65.2M | 65.4M | 85.4M |
Stock-based compensation expense | 15.8M | 15.9M | 13.2M | 12.1M | 10.5M | 0 | 12.6M | 14.8M | 14.1M | 7.9M |
| Deferred income tax benefit | 15.8M | 15.9M | 13.2M | 12.1M | 10.5M | 0 | 12.6M | 14.8M | 14.1M | 7.9M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 39M | -24.7M | -10.8M | 45.8M | -800K | 67.4M | -15.3M | 8.4M | 9M | 15.1M |
Inventories | 4.7M | -30.9M | 17.2M | -21.8M | -21.3M | -34.5M | -16.8M | 41M | -20.2M | -2.9M |
Accounts payable | -14.4M | 35.4M | -11.9M | -18.9M | -83.6M | -64M | 18.8M | 6.5M | 14.7M | 4.5M |
Cash generated by operating activities | 32.4M | 90.9M | 87.3M | -2.5M | -74.5M | -145.6M | 144.2M | 188.8M | 97.6M | 147.9M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -17.8M | -19.3M | -21M | -20.2M | -50.6M | -49.1M | -43.2M | -29.1M | -70.4M | -78.5M |
Acquisitions Net | 39.4M | -116.1M | 0 | -4M | -57.5M | 688.6M | 100K | -175M | 7.8M | 0 |
Cash generated by investing activities | 21.6M | -135.4M | -21M | -24.2M | -108.1M | 639.5M | -43.1M | -200.9M | -62.6M | -70.7M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 6.2M | 3.4M | 0 | 17.1M | 0 | 400K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -680M |
Repurchases of common stock | -19.1M | -45.5M | -11.5M | -900K | -3.6M | -900K | -2.5M | -900K | -1M | 0 |
Repayments of term debt | -64.7M | 103.4M | -70M | -254.8M | -200K | -339M | 0 | -72M | -51M | -13.8M |
Cash used in financing activities | -94.2M | 56.7M | -55.3M | -70M | 1.5M | -324.4M | 2.2M | -1.4M | -50.6M | 29.2M |
Net Change In Cash | -40M | 9.2M | 7M | -93.8M | -179.2M | 164.8M | 106M | -15.8M | -19.5M | 104.9M |
Cash at end of period | 87.7M | 127.7M | 118.5M | 111.5M | 205.3M | 384.5M | 219.7M | 113.7M | 129.5M | 149M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |